A head tilt is the rat holding her head visibly to one side, often with circling, falling, rolling, or apparent disorientation. Some rats also show nystagmus (rapid rhythmic eye movements). These are signs of disturbed balance and can arise from disease in the inner ear or its connections in the brain.[1][2]
Treating a rat? Work out the dose with the Roof Rat Medication Dosing Calculator.
Head tilt has several possible causes. Common possibilities in pet rats include middle- or inner-ear infection and central neurological disease such as a pituitary tumor. The symptoms overlap. Timing, associated signs, and the angle of the tilt can help weight the differential, but none identifies the cause by itself.[2][3] The first step is an urgent veterinary examination.
1. Mycoplasma-associated ear infection
How it can present: Respiratory signs may accompany the head tilt: discharge around the nose and inner corners of the eyes, sneezing, or an audible rattle or click when she breathes.[4] Their absence does not rule out middle- or inner-ear infection, and a sudden tilt does not prove that the underlying disease is new.[3][5] Norway rats may show red porphyrin staining around the eyes or nose.[4] In a roof rat, watch for CLEAR discharge, not red. “I’ve never seen any roof rat get porphyrin. Their discharge is clear, and if you see it, it is usually a sign of serious infection.” (the breeder, from his own account)
Why it happens: Mycoplasma pulmonis can spread from the respiratory tract through the Eustachian tube into the middle ear and, from there, the inner ear.[4][1] It is one possible organism, not a diagnosis that can be made from the head tilt alone. Treatment: Rat Guide lists doxycycline with enrofloxacin when combination therapy is needed for suspected mycoplasmal disease.[4][1] This is rat clinical guidance for controlling signs, not proof that the combination cures every infection. See the dedicated mycoplasma article.
2. Other bacterial ear infections
How they can present: A severe tilt, rolling, pain, or visible purulent discharge can occur with bacterial middle- or inner-ear disease. The signs may appear suddenly even when destructive disease has been developing for some time, and neither a very severe angle nor the absence of respiratory signs identifies the organism.[1][5][3]
Why it happens: Companion-rat ear infections can involve mycoplasma and other bacteria, sometimes with more than one organism present.[3] A veterinary pathology reference lists Pasteurella, Streptococcus, and Staphylococcus among possible bacterial causes and describes possible eardrum rupture.[5] Treatment: amoxicillin-clavulanate may cover susceptible non-mycoplasmal bacteria, but it does not act on cell-wall-free mycoplasma.[6][4] Chloramphenicol crosses the blood-brain barrier and Rat Guide lists it as one possible component of combination therapy; a veterinarian may select it for a serious infection when its penetration, the likely organism, and its risks justify use.[7][1] Drug combinations need veterinary selection, including consideration of interactions.[7]
3. Pituitary tumor (prolactinoma)
How it can present: Rat Guide describes prolactinomas particularly in older females, often 13 to 24 months, while noting that pituitary tumors also occur in males. Signs often develop gradually, although they may seem sudden to the owner. Warning signs can include paw knuckling (walking on the top of a paw), impaired forelimb use, difficulty picking up or holding food, vision loss, behavior change, weakness, or lactation in a non-pregnant female. Some tumors compress nearby brain tissue or the optic nerves.[8] These clues prompt investigation; they do not establish the diagnosis. On the breeder’s judgement that the underlying biology is conserved, we also use these warning signs for roof rats. This is an extrapolation from rat clinical guidance, not a roof-rat case series.
What the studies show: Many spontaneous pituitary adenomas in aging laboratory Norway rats contain prolactin-producing cells. In a series of 90 adenomas, 53% contained prolactin-immunoreactive cells; 33% were pure prolactinomas and 20% were multihormonal prolactinomas.[9] Treatment: Cabergoline is a dopamine D2 receptor agonist that reduces prolactin secretion. Laboratory research found that it induced cell death in rat pituitary tumor cell lines.[10] In a published case involving a 24-month-old male pet rat, an MRI-confirmed pituitary mass was substantially smaller after two months of cabergoline treatment. The rat remained free of clinical signs for the following six months, but the mass had substantially regrown 8.5 months after treatment began.[11] This single case shows that improvement and later recurrence are possible; it does not establish a typical extension of good-quality life for pet rats. Rat Guide says treatment may extend quality time by three to six months depending on when it begins; that is conditional clinical guidance, not a measured average or guarantee.[8] See the dedicated pituitary tumor article.
How a vet tells them apart
A veterinarian combines the history with an ear, physical, and neurological examination. Age, onset, and associated signs help rank the possible causes. Respiratory signs, ear discharge, and ear pain support investigating ear disease, while impaired forelimb use, difficulty handling food, vision or behavior change, lactation, and the older-female pattern support investigating pituitary disease.[2][3][8] No single clue establishes the cause. Otoscopy, culture when a sample can be obtained, and imaging are useful options when available to locate the disease and choose treatment.[1][2]
A veterinarian may use a carefully selected treatment trial for both treatment and diagnostic information, weighing its likely benefit, safety, cost, and time to response against the available tests. Improvement with appropriately selected antibiotics supports infection as a working diagnosis; interpretation also depends on treatment duration and any other medicines given. Lack of improvement should prompt reassessment of the regimen and differential rather than rule out infection, and some rats retain a residual tilt after infection is controlled.[1][4]
Supportive care matters during treatment: keep the rat in a safe, low enclosure and keep food and water within reach. Recovery can take time, and some rats retain a head tilt after treatment.[1]
Walk through the differential interactively
Our JUSTICE LEAGUE vs THE HEAD TILT text adventure makes you the owner of a rat in distress, with two veterinary consultants on the phone. The villain is chosen randomly at game start: one of three. You learn the differential by playing it out, multiple times, with different villains. Type AGAIN for a different case, REPEAT to try the same one again.
References
- [1] The Rat Guide. “Otitis Media, Otitis Interna / Labyrinthitis.” link.
- [2] Hollwarth A. “Management of head tilts in small mammals.” Veterinary Practice 2024. link.
- [3] McCready JE, Langohr IM, Barboza T, de Cecco BS, James F, Piero FD, Brandão J. “Concurrent respiratory pathology and intracranial extension are common in companion rats (Rattus norvegicus) with otitis media/interna (23 cases, 2011-2025).” The Veterinary record 2026. PubMed.
- [4] The Rat Guide. “Rat Respiratory Disease: Mycoplasma pulmonis (Mycoplasmosis).” link.
- [5] Joint Pathology Center. “Wednesday Slide Conference 2014-2015, Conference 17, Case 1: Rat, chronic suppurative otitis media and interna.” 2015. link.
- [6] The Rat Guide. “Clavamox (amoxicillin/clavulanate).” link.
- [7] The Rat Guide. “Chloramphenicol.” link.
- [8] The Rat Guide. “Pituitary Tumor.” link.
- [9] Carretero J, Burks DJ, Vazquez G, Rubio M, Hernandez E, Bodego P, Vazquez R. “Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats.” Pituitary 2002;5(1):5-10. PubMed.
- [10] Lin SJ et al. “Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline.” Oncotarget 2015;6(36):39329-39341. PubMed.
- [11] Mayer J et al. “Extralabel use of cabergoline in the treatment of a pituitary adenoma in a rat.” Journal of the American Veterinary Medical Association 2011;239(5):656-660. PubMed.